Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Related press release
Associated IMPL transcripts
IMPL similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-255487) pertaining to the 2021 Equity Incentive Plan, 2021 Employee Stock Purchase Plan, 2018 Equity Incentive Plan, and 2008 Equity Incentive Plan of Impel Neuropharma, Inc. of our report dated March 29, 2022, with respect to the consolidated financial statements of Impel Neuropharma, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Seattle, Washington
March 29, 2022